Search bioRxiv⌕ Search

Biology subjects

Katzir, I.

Publications and source records attributed to Katzir, I..

2 recordsLinked to original sources

Design of bacterial DNT sensors based on computational models

Detecting explosive compounds such as 2,4,6-trinitrotoluene (TNT) and its volatile byproduct 2,4-dinitrotoluene (DNT) is paramount for public health and environmental safety. In this study, we present the successful application of diverse computational and data analysis models toward developing a bacterial biosensor engineered to detect DNT with high sensitivity and specificity. The Escherichia coli-based biosensor harbors a plasmid-based fusion of a gene promoter acting as the sensing element to a microbial bioluminescence gene cassette as the reporter. By analyzing endogenous and heterologous promoter data under conditions of DNT exposure, a total of 367 novel variants were generated. The biosensors engineered with these modifications demonstrated a remarkable amplification of up to 4-fold change in signal intensity upon exposure to 2,4-dinitrotoluene compared to non-modified biosensors, accompanied by a decrease in the detection threshold. Our analysis suggests that the sequence features with the highest contribution to biosensor performances are DNA folding patterns and nucleotide motifs associated with DNT sensing. These computational insights guided the rational design of the biosensor, leading to significantly improved DNT detection capabilities compared to the previous biosensor strain. Our results demonstrate the effectiveness of integrating computational modeling with synthetic biology techniques to develop advanced biosensors tailored for environmental monitoring applications. A similar approach may be applied to a wide array of ecological, industrial, and medical sensing endeavors.

synthetic biology↗

Small Extracellular Vesicles from Failing Heart Accelerate Tumor Growth

BackgroundMyocardial infarction (MI) and heart failure (HF) are associated with an increased incidence of cancer. The mechanism is complex and unclear. Here, we aimed to test our hypothesis that cardiac small extracellular vesicles (sEVs), particularly cardiac mesenchymal stromal cells-derived sEVs (cMSC-sEVs), contribute to the link between post-MI HF and cancer. MethodsWe purified and characterized sEVs from the whole heart and cultured cMSCs. Then, we analyzed cMSC-EV cargo and pro-neoplastic effects on several types of cancer cell lines, macrophages, and endothelial cells. Next, we modeled post-MI HF along with heterotopic and orthotopic lung and breast cancer tumors in mice. We used cMSC-sEV transfer to assess sEV biodistribution and its effect on tumor growth. Finally, we tested the effects of sEV depletion and spironolactone treatment on cMSC-EV release and tumor growth. ResultsPost-MI hearts, particularly cMSCs, produced more sEVs with pro-neoplastic cargo than non-failing hearts did. Proteomic analysis revealed unique protein profiles and higher quantities of tumor-promoting cytokines, proteins, and microRNAs in cMSC-sEVs from failing hearts. The pro-neoplastic effects of cMSC-sEVs varied with different types of cancer cells, substantially affecting lung cancer cells relative to other more aggressive cancer cell lines. We also found that post-MI cMSC-sEVs activated resting macrophages into pro-angiogenic and pro-tumorigenic states in vitro. At 28-day follow-up analysis, mice with post-MI HF developed larger lung tumors than did sham-MI mice. Adoptive transfer of cMSC-sEVs from failing hearts accelerated lung tumor growth, and biodistribution analysis revealed an accumulating cMSC- sEVs in tumor cells along with accelerated tumor cell proliferation. Significantly, sEV depletion reduced the tumor-promoting effects of HF, and adoptive transfer of cMSC-sEVs from failing hearts partially restored it. Finally, post-MI spironolactone treatment reduced the number of cMSC-sEVs and suppressed tumor growth during post-MI HF. ConclusionsFor the first time, we show that cardiac sEVs, specifically cMSC-sEVs from post-MI failing hearts, carry multiple pro-tumorigenic factors. Uptake of cMSC-sEVs by cancer cells accelerates tumor growth. Post-MI spironolactone treatment reduces the associated tumor growth. Thus, we provide new insight into the link between post-MI HF and cancer and propose a translational option to mitigate this deadly association.

cancer biology↗